SS
VNDA icon

Sunbelt Securities’s Vanda Pharmaceuticals VNDA Stock Holding History

Sunbelt Securities’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$477 Hold
69
– – ﹤0.01% 2300
2025
Q4 		$609 Sell
69
-8
-10% -$44 ﹤0.01% 2191
2025
Q3 		$384 Buy
+77
New +$356 ﹤0.01% 2292

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sunbelt Securities's VNDA Position: Q1 2026 in Review

Sunbelt Securities held its Vanda Pharmaceuticals (VNDA) position steady in Q1 2026 at 69 shares worth $477. The position accounts for ﹤0.01% of the portfolio, ranked #2300.

Sunbelt Securities first reported a position in VNDA in Q3 2025 and has held it in 3 quarters since. The position peaked at $609 in Q4 2025. 171 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Sunbelt Securities held 69 shares of Vanda Pharmaceuticals worth $477 as of Q1 2026.
  • Sunbelt Securities left its Vanda Pharmaceuticals share count unchanged in Q1 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2300 holding.
  • Sunbelt Securities first reported a position in Vanda Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Sunbelt Securities's Vanda Pharmaceuticals position peaked at $609 in Q4 2025.
  • 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.